Penumbra Reaches New Heights with Ruby® XL, Advancing Precision in Vascular Embolization

The launch of Ruby® XL represents a breakthrough in vascular embolization, offering physicians unprecedented flexibility and efficiency for complex case management.

In an exclusive conversation with MedTech Spectrum, Ms. Shruthi Narayan, President, Interventional at Penumbra, discusses how the Ruby® XL System is setting a new benchmark in vascular embolization. Engineered to be the world’s longest, largest, and softest coil, Ruby® XL is designed to enhance control, precision, and efficiency in treating complex, high-volume cases. With its unmatched performance characteristics, the system empowers physicians to achieve faster occlusion and reduce procedural complexity. As Penumbra continues to lead innovation in interventional care, Ruby® XL reinforces its commitment to delivering transformative technologies that improve both clinician workflow and patient outcomes.

What inspired the development of the Ruby® XL System, and how does it address unmet needs in complex embolization procedures?

The inspiration for Ruby XL came from physician feedback and the need for a larger, longer, softer coil compatible with diagnostic catheters. The Ruby XL System is designed to provide what physicians have been asking for: a coil platform with more volume and fewer exchanges that can be delivered without a microcatheter. The system addresses a lot of the limitations of existing .035 coils, delivering mechanical occlusion through more volume without sacrificing softness or deliverability.

Sign up for Blog Updates